Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Global Health, University of Washington, Seattle, WA, USA.
Lancet Glob Health. 2018 Jul;6(7):e758-e768. doi: 10.1016/S2214-109X(18)30283-3.
The protozoan Cryptosporidium is a leading cause of diarrhoea morbidity and mortality in children younger than 5 years. However, the true global burden of Cryptosporidium infection in children younger than 5 years might have been underestimated in previous quantifications because it only took account of the acute effects of diarrhoea. We aimed to demonstrate whether there is a causal relation between Cryptosporidium and childhood growth and, if so, to quantify the associated additional burden.
The Global Burden of Diseases, Injuries, and Risk Factors study (GBD) 2016 was a systematic and scientific effort to quantify the morbidity and mortality associated with more than 300 causes of death and disability, including diarrhoea caused by Cryptosporidium infection. We supplemented estimates on the burden of Cryptosporidium in GBD 2016 with findings from a systematic review of published and unpublished cohort studies and a meta-analysis of the effect of childhood diarrhoea caused by Cryptosporidium infection on physical growth.
In 2016, Cryptosporidium infection was the fifth leading diarrhoeal aetiology in children younger than 5 years, and acute infection caused more than 48 000 deaths (95% uncertainty interval [UI] 24 600-81 900) and more than 4·2 million disability-adjusted life-years lost (95% UI 2·2 million-7·2 million). We identified seven data sources from the scientific literature and six individual-level data sources describing the relation between Cryptosporidium and childhood growth. Each episode of diarrhoea caused by Cryptosporidium infection was associated with a decrease in height-for-age Z score (0·049, 95% CI 0·014-0·080), weight-for-age Z score (0·095, 0·055-0·134), and weight-for-height Z score (0·126, 0·057-0·194). We estimated that diarrhoea from Cryptosporidium infection caused an additional 7·85 million disability-adjusted life-years (95% UI 5·42 million-10·11 million) after we accounted for its effect on growth faltering-153% more than that estimated from acute effects alone.
Our findings show that the substantial short-term burden of diarrhoea from Cryptosporidium infection on childhood growth and wellbeing is an underestimate of the true burden. Interventions designed to prevent and effectively treat infection in children younger than 5 years will have enormous public health and social development impacts.
The Bill & Melinda Gates Foundation.
原生动物隐孢子虫是导致 5 岁以下儿童腹泻发病率和死亡率的主要原因。然而,在以前的定量分析中,隐孢子虫感染对 5 岁以下儿童的真正全球负担可能被低估了,因为它只考虑了腹泻的急性影响。我们旨在证明隐孢子虫与儿童生长之间是否存在因果关系,如果存在,那么量化相关的额外负担。
全球疾病、伤害和危险因素研究(GBD)2016 是一项系统和科学的努力,旨在量化与 300 多种死亡和残疾原因相关的发病率和死亡率,包括由隐孢子虫感染引起的腹泻。我们用系统综述发表和未发表的队列研究结果和隐孢子虫感染引起的儿童腹泻对身体生长影响的荟萃分析来补充 GBD 2016 中关于隐孢子虫负担的估计。
2016 年,隐孢子虫感染是 5 岁以下儿童第五大腹泻病因,急性感染导致超过 48000 人死亡(95%置信区间 [CI] 24600-81900)和超过 420 万残疾调整生命年损失(95% CI 220 万-720 万)。我们从科学文献中确定了七个数据源和六个个体水平数据源,描述了隐孢子虫与儿童生长之间的关系。隐孢子虫感染引起的每次腹泻都与身高年龄 Z 评分(0.049,95%CI 0.014-0.080)、体重年龄 Z 评分(0.095,0.055-0.134)和体重身高 Z 评分(0.126,0.057-0.194)的降低有关。我们估计,在考虑到其对生长迟缓的影响后,隐孢子虫感染引起的腹泻导致额外增加了 785 万残疾调整生命年(95%CI 542 万-1011 万),比仅考虑急性影响的估计值高出 153%。
我们的研究结果表明,隐孢子虫感染对儿童生长和健康的大量短期腹泻负担是对真实负担的低估。旨在预防和有效治疗 5 岁以下儿童感染的干预措施将对公共卫生和社会发展产生巨大影响。
比尔和梅琳达盖茨基金会。